These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33553657)

  • 1. Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis.
    Kaji K; Okita K; Suzuki K; Sato I; Fujisawa M; Yoshiji H
    JGH Open; 2021 Feb; 5(2):207-212. PubMed ID: 33553657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.
    Bale A; Pai CG; Shetty S; Balaraju G; Shetty A
    J Clin Exp Hepatol; 2018 Jun; 8(2):156-161. PubMed ID: 29892178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study.
    Kondo Y; Iwasa M; Kawaratani H; Miyaaki H; Hanai T; Kon K; Hirano H; Shimizu M; Yoshiji H; Okita K; Koike K
    Hepatol Res; 2021 Jun; 51(6):674-681. PubMed ID: 33615662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.
    Zhang LJ; Qi R; Zhong J; Xu Q; Zheng G; Lu GM
    PLoS One; 2012; 7(8):e42824. PubMed ID: 22912746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
    Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials.
    Kawaguchi T; Suzuki F; Imamura M; Murashima N; Yanase M; Mine T; Fujisawa M; Sato I; Yoshiji H; Okita K; Suzuki K
    Hepatol Res; 2019 Apr; 49(4):404-418. PubMed ID: 30589492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
    Bajaj JS; Riggio O; Allampati S; Prakash R; Gioia S; Onori E; Piazza N; Noble NA; White MB; Mullen KD
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1511-6. PubMed ID: 23707462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization.
    Bai Z; Guo X; Tacke F; Li Y; Li H; Qi X
    Therap Adv Gastroenterol; 2019; 12():1756284819881302. PubMed ID: 31636711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.
    Rathi S; Chopra M; Chouduri G; Sharma P; Madan K; Chhabra M; Rai RR; Govil A; Konar A; Goenka M; Agarwal M; Mukherjee J; Thorat V; Salunkhe S; Abraham P; Nagral A; Jhaveri A; Bhat N; Varghese J; R S A; Ravishankar ; Reddy DC; Dhiman RK
    J Clin Exp Hepatol; 2019; 9(4):476-483. PubMed ID: 31516264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Riggio O; Amodio P; Farcomeni A; Merli M; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Piazza N; De Rui M; Schiff S; Montagnese S
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1346-52. PubMed ID: 25572976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
    Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
    Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
    Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of albumin-bilirubin grade combined with serum ammonia in cirrhosis with hepatic encephalopathy].
    Hou YL; Gao MD; Guo HY; Wang R; Wang Z; Yu YH; Lou JL; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):127-131. PubMed ID: 29343038
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors.
    Nicoletti V; Gioia S; Lucatelli P; Nardelli S; Pasquale C; Nogas Sobrinho S; Pentassuglio I; Greco F; De Santis A; Merli M; Riggio O
    Dig Liver Dis; 2016 Sep; 48(9):1072-7. PubMed ID: 27448844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Zheng G; Lu H; Yu W; Luo S; Liu Y; Liu W; Liu H; Wu L; Zheng L; Kong X; Zhang LJ; Lu GM
    Eur Radiol; 2017 Nov; 27(11):4699-4709. PubMed ID: 28523351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.
    Lin X; Gao F; Wu X; Cai W; Chen X; Huang Z
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):862-871. PubMed ID: 32541240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.